Announcements
- Notice of results
- BOARD CHANGE
- Arecor and TRx Biosciences research collaboration
- Arecor announces launch of Ogluo® in Netherlands
- Year End Trading Update
- Arecor announces update on INBRX-101
- Arecor granted key European patent
- Expansion of specialty hospital collaboration
- Appointment of SVP for Tetris Pharma Ltd
- Agreement with global medical products company
More ▼
Key statistics
As of last trade Arecor Therapeutics PLC (6UI:DUS) traded at 1.54, -6.10% below its 52-week high of 1.64, set on Apr 08, 2024.
52-week range
Open | 1.56 |
---|---|
High | 1.56 |
Low | 1.54 |
Bid | 1.53 |
Offer | 1.65 |
Previous close | 1.54 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.63m |
Free float | 14.86m |
P/E (TTM) | -- |
Market cap | 42.11m GBP |
EPS (TTM) | -0.3108 GBP |
Data delayed at least 15 minutes, as of May 02 2024 15:32 BST.
More ▼